Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,152,780
+$200,808 QoQ
Shares Held
8,555
-4.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#1,908
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Knuff & Co LLC holds $24,047,308 across 10 Drug Manufacturers - General names. ABBV ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
242,776 | $11,638,681 | |
| 2 | JNJ |
Johnson & Johnson
|
10,973 | $2,786,812 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
17,641 | $2,228,763 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
8,555 | $2,152,780 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,038 | $1,675,383 | |
| 6 | PFE |
Pfizer Inc
|
63,859 | $1,537,724 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,438 | $947,157 | |
| 8 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,152,780 | 8,555 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,951,972 | 8,975 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,730,811 | 7,575 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,755,073 | 7,580 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,406,999 | 7,580 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,653,950 | 7,894 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,402,763 | 7,894 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,535,407 | 7,775 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,350,720 | 7,875 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,461,352 | 8,025 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,243,634 | 8,025 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,196,206 | 8,025 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,101,417 | 8,175 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,398,471 | 8,775 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,417,319 | 8,770 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,197,153 | 8,920 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,469,570 | 9,595 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,555,445 | 9,595 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,262,875 | 9,327 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,068,668 | 9,907 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,117,614 | 9,922 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,073,758 | 9,922 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,065,821 | 9,947 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $860,133 | 9,820 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $930,746 | 9,480 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $606,091 | 7,955 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||